Investor Relations

Stock Information

Date	Title
Toggle Summary11/04/19	Luminex Corporation Reports Third Quarter 2019 Results and Submission of VERIGENE II Gastrointestinal Flex Assay to the FDA AUSTIN, Texas , Nov. 4, 2019 /PRNewswire/ -- Luminex Corporation (Nasdaq: LMNX) today announced results for its third quarter ended September 30, 2019 . All amounts in this release are in conformity with U.S. generally accepted accounting principles ("GAAP").
Toggle Summary10/25/19	Luminex Corporation To Release Third Quarter 2019 Results After Market Close On November 4, 2019 AUSTIN, Texas , Oct. 25, 2019 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that it plans to report results for the third quarter ended September 30, 2019 on Monday, November 4, 2019 after the market close. The company will host a conference call that day at 5:00 p.m.

Date	Event Details
Summary Toggle 11/04/19 5:00 PM EST Monday, November 04, 2019 5:00 PM EST	Q3 2019 Luminex Corp Earnings Conference Call Supporting Materials Q3 2019 Conference Call Investor Presentation 526 KB Q3 Financial Results Press Release 550.5 KB
Summary Toggle 10/02/19 2:50 PM EDT Wednesday, October 02, 2019 2:50 PM EDT	Investor Presentation Click here to download presentation